GAMBERI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 527
EU - Europa 346
AS - Asia 244
AF - Africa 21
OC - Oceania 4
SA - Sud America 1
Totale 1.143
Nazione #
US - Stati Uniti d'America 527
VN - Vietnam 94
IT - Italia 92
GB - Regno Unito 76
SG - Singapore 57
SE - Svezia 53
CN - Cina 51
DE - Germania 41
IN - India 29
IE - Irlanda 18
RU - Federazione Russa 12
FI - Finlandia 11
FR - Francia 10
CI - Costa d'Avorio 8
EE - Estonia 7
TG - Togo 7
BG - Bulgaria 6
JO - Giordania 6
UA - Ucraina 6
ZA - Sudafrica 6
AU - Australia 4
NL - Olanda 4
BE - Belgio 2
ID - Indonesia 2
IL - Israele 2
IR - Iran 2
LT - Lituania 2
CZ - Repubblica Ceca 1
ES - Italia 1
HR - Croazia 1
MK - Macedonia 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
RO - Romania 1
Totale 1.143
Città #
Fairfield 70
Southend 69
Chandler 60
Singapore 55
Dong Ket 52
Ashburn 51
Woodbridge 34
Houston 30
Seattle 25
Cambridge 22
Santa Clara 22
Bologna 20
Wilmington 19
Dublin 18
Princeton 16
Boardman 14
Ann Arbor 13
Helsinki 11
Redmond 10
Milan 9
Abidjan 8
Hyderabad 8
Berlin 7
Lomé 7
Amman 6
Pune 6
Salsomaggiore Terme 6
San Diego 6
Sofia 6
Westminster 6
Beijing 5
Bremen 5
Florence 5
Padova 5
Rome 5
Turin 5
Munich 4
Saint Petersburg 4
Falls Church 3
Jiaxing 3
Leawood 3
Melbourne 3
Nanchang 3
Nanjing 3
Porto Recanati 3
Pozzo 3
Redwood City 3
Reggio Calabria 3
Udine 3
Zhengzhou 3
Breda 2
Brussels 2
Cernusco sul Naviglio 2
Codogno 2
Des Moines 2
Hangzhou 2
Jakarta 2
Jerusalem 2
Jinan 2
Kuban 2
London 2
Modena 2
New York 2
Norwalk 2
Paris 2
Shrewsbury 2
Taizhou 2
Xi'an 2
Abano Terme 1
Brno 1
Cagliari 1
Changchun 1
Changsha 1
Dallas 1
Dearborn 1
Dongguan 1
Groningen 1
Guangzhou 1
Hanover 1
Hebei 1
Jinzhong 1
Kilburn 1
Lima 1
Los Angeles 1
Madrid 1
Mason 1
Moscow 1
Mumbai 1
Nuremberg 1
Olalla 1
Orange 1
Penrith 1
San Felice sul Panaro 1
Seversk 1
Shanghai 1
Shenyang 1
Shenzhen 1
Stoke-on-Trent 1
Suzhou 1
Tallinn 1
Totale 828
Nome #
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 217
Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma 148
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study 135
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe) 123
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma 120
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe) 118
Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma 96
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis 94
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 50
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 33
Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy 27
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial 20
Totale 1.181
Categoria #
all - tutte 3.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.438


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020148 0 0 0 0 0 24 28 30 27 21 11 7
2020/2021153 18 7 2 4 4 3 1 20 16 7 9 62
2021/2022234 49 10 17 20 20 6 4 12 2 16 46 32
2022/2023242 21 37 7 39 17 17 8 13 51 4 17 11
2023/2024101 15 16 2 4 7 24 5 12 2 1 11 2
2024/2025167 24 31 31 31 38 12 0 0 0 0 0 0
Totale 1.181